In-Vitro, Anti-Bacterial Activities of Aqueous Extracts of Acacia catechu (L.F.)Willd, Castanea sativa, Ephedra sinica stapf and shilajita mumiyo Against Gram Positive and Gram Negative Bacteria
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Evaluations of the in-vitro anti-bacterial activities of aqueous extracts of Acacia catechu (L.F.)Willd, Castanea sativa, Ephedra sinica stapf and Shilajita mumiyo against gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumonia) and gram-negative bacteria (Escherichia coli, klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa) are reasonable since these ethnomedicinal plants have been used in Persian folk medicine for treating skin diseases, venereal diseases, respiratory problems and nervous disorders for ages. Methods: The well diffusion method (KB testing) with a concentration of 250 μg/disc was used for evaluating the minimal inhibitory concentrations (MIC). Maximum synergistic effects of different combinations of components were also observed. Results: A particular combination of Acacia catechu (L.F.) Willd, Castanea sativa, Ephedra sinica stapf and shilajita mumiyo extracts possesses an outstanding anti-bacterial activity. It's inhibiting effect on microorganisms is significant when compared to the control group (P < 0.05). Staphylococcus aureus was the most sensitive microorganism. The highest antibacterial activity against gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumonia) or gram-negative bacteria (Escherichia coli, Klebsiella pneumonia, Proteus mirabilis, and Pseudomonas aeruginosa) was exerted by formula number 2 (table 1). Conclusion: The results reveal the presence of antibacterial activities of Acacia catechu, Castanea sativa husk, Ephedra sp. and Mumiyo against gram-positive and gram-negative bacteria. Synergistic effects in a combined formula, especially in formula number 2(ASLANⓇ) can lead to potential sources of new antiseptic agents for treatment of acute or chronic skin ulcers. These results considering the significant antibacterial effect of the present formulation, support ethnopharmacological uses against diarrheal and venereal diseases and demonstrate use of these plants to treat infectious diseases.
Abstract
Objective: Evaluations of the in-vitro anti-bacterial activities of aqueous extracts of Acacia catechu (L.F.)Willd, Castanea sativa, Ephedra sinica stapf and Shilajita mumiyo against gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumonia) and gram-negative bacteria (Escherichia coli, klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa) are reasonable since these ethnomedicinal plants have been used in Persian folk medicine for treating skin diseases, venereal diseases, respiratory problems and nervous disorders for ages. Methods: The well diffusion method (KB testing) with a concentration of 250 μg/disc was used for evaluating the minimal inhibitory concentrations (MIC). Maximum synergistic effects of different combinations of components were also observed. Results: A particular combination of Acacia catechu (L.F.) Willd, Castanea sativa, Ephedra sinica stapf and shilajita mumiyo extracts possesses an outstanding anti-bacterial activity. It's inhibiting effect on microorganisms is significant when compared to the control group (P < 0.05). Staphylococcus aureus was the most sensitive microorganism. The highest antibacterial activity against gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumonia) or gram-negative bacteria (Escherichia coli, Klebsiella pneumonia, Proteus mirabilis, and Pseudomonas aeruginosa) was exerted by formula number 2 (table 1). Conclusion: The results reveal the presence of antibacterial activities of Acacia catechu, Castanea sativa husk, Ephedra sp. and Mumiyo against gram-positive and gram-negative bacteria. Synergistic effects in a combined formula, especially in formula number 2(ASLANⓇ) can lead to potential sources of new antiseptic agents for treatment of acute or chronic skin ulcers. These results considering the significant antibacterial effect of the present formulation, support ethnopharmacological uses against diarrheal and venereal diseases and demonstrate use of these plants to treat infectious diseases.
참고문헌 (19)
- Wrangham RW, "Aspilia spp. leaves: A puzzle in the feeding behavior of wild chimpanzees", Primates, 24(2), pp.276~282 (1983)
- Huffman MA, "Current evidence for self-medication in primates: A multidisciplinary perspective", Am J Phys Anthropol, 104(Suppl 25), pp.171~200 (1997)
- Cox PA, "The ethnobotanical approach to drug discovery: strengths and limitations", Ciba Found Symp, 185, pp.25~36 (1994)
- Kamboj VP, "Herbal medicine", Current Science, 78(1), pp.35~39 (2000)
- Pal SK, "Herbal medicine: Past present and the future", Asian Pac J Cancer Prev, 4(4), pp.281~288 (2003)
- Naghibi F, "Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology", Iranian Journal of Pharmaceutical Research, 4(2), pp.63~79 (2005)
- Evans M. A guide to herbal remedies. Orient Press;, "A guide to herbal remedies", pp.96~ (1994), Orient Press
- Gottlieb OR, "Phytochemicals: differentiation and function", Photochemistry, 29(6), pp.1715~1724 (1990)
- Gottlieb OR, "Lignans, In Natural products of woody plants I", pp.349~511 (1989), Springer- Verlag
- Spinella M, "The importance of pharmacological synergy in psychoactive herbal medicines", Altern Med Rev, 7(2), pp.130~137 (2002)
- National Committee for Clinical Laboratory Standards, "Performance standards for anti-microbial disk susceptibility tests: approved standard M2-A7", National Committee for Clinical Laboratory Standards, 52~ (1997)
- Rios JL, "Screening methods for natural products with anti-microbial activity: a review of the literature", J Ethnopharmacol, 23(2-3), pp.127~149 (1988)
- Hammer KA, "Anti-microbial activity of essential oils and other plant extracts", J Appl Microbial, 86(6), pp.985~990 (1999)
- Junior A, "Biological screening of Brazilian medicinal plants", Bra J Sci, 95(3), pp.367~373 (2000)
- National Committee for Clinical Laboratory Standards, "Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard. NCCLS document M27-A", National Committee for Clinical Laboratory Standards, ~ (1997)
- Andrews JM, "Determination of minimum inhibitory concentration", J Antimicrob Chemother, 48(Suppl 1), pp.5~16 (2001)
- Mandal S, "Evaluation of combination effect of ciprofloxacin and cefazolin against Salmonella enteric serovar typhi isolates by in vitro methods", Calicut Med J, 2(2), pp.e2~ (2004)
- Eliopoulos GM, "Antibiotics in laboratory medicine, Chapter 9, Antimicrobial combinations", pp.330~338 (1996), Williams & Wilkins
- Pelt JM, "Drugs and magic plants", pp.336~ (1983), Librairie Artheme Fayard